TABLE 5.

Representative therapeutic antibodies strategies for CoV infections.

Name of drugs	Mechanism of action	In vitro	In vivo	Clinical trial	Approved	References
Dexamethasone	Prevents the release of substances in the body that cause inflammation	N.A.	N.A.	SARS-CoV-2	Prevents inflammation	Recovery Collaborative Group et al., 2020; Atyeo et al., 2021
Tocilizumab	Anti-IL-6	N.A.	N.A.	SARS-CoV-2	Adult patients with active rheumatoid arthritis	Stone et al., 2020
Sarilumab	Anti-IL-6R	N.A.	N.A.	SARS-CoV-2	Moderates to severe active rheumatoid arthritis	Castelnovo et al., 2021